SIVS Executive Committee

Dr. Richard Rupp is the Director of the Sealy Institute for Vaccine Sciences Clinical Trials Program. He has been the Principal Investigator for dozens of trials spanning the spectrum from infants through the elderly. He is board certified in Pediatrics as well as in Adolescent Medicine. Dr. Rupp's expertise in Adolescent Medicine has been particularly helpful in the success of trials involving teens. In his role as Director of Clinical Trials, he ensures that his group has the highest level of commitment to quality and ethical standards. Additionally, Dr. Rupp has more than two decades of experience working within public schools on health related issues including efforts to enhance immunization uptake.

Dr. Beasley is an internationally recognized expert in the field of molecular biology of flaviviruses. His research focuses on the plasticity of flavivirus envelope protein sequences and the molecular basis for phenotypic variations between individual strains and major groups of flaviviruses, with the goal of developing and evaluating new and improved vaccines, diagnostics and therapeutics. He also served as a Co-Director of UTMB's select agent BSL-3 laboratories and was the Director of the Galveston National Laboratory Regulatory Compliance Core. Dr. Beasley has been actively involved in UTMB's preparations for conduct of regulated nonclinical studies at BSL3/4 since 2005, with an emphasis on development and use of animal models for testing and approval of new vaccines and therapeutics under the FDA's Animal Rule. In addition, Dr. Beasley is the Associate Director of the World Health Organization Collaborating Center (WHO CC) for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases.

Dr. Megan Berman is an Associate Professor of Internal Medicine. She is board certified in internal medicine and is a practicing internist in both the inpatient and outpatient settings. Her expertise is in chronic disease management and preventive care. She is the lead physician educating health professionals on adult immunization throughout UTMB. She works closely with the Internal Medicine residency program on quality improvement projects that have included vaccinations. Additionally, she is involved institutionally with UTMB’s immunization EPIC Task Force and as a sub-investigator for research vaccine trails with SIVS.

Dr. Milligan is an expert in the field of viral immunology and serves as Senior Scientist on both the SIVS Executive Committee and the World Health Organization Collaborating Center (WHO CC) on Vaccine Research, Evaluation and Training on Emerging Infectious Diseases Committee. His research focuses on cell-mediated immunity to viruses. Dr. Milligan utilizes a genital herpes simplex virus infection of mice as a model of epithelial and neuronal viral infection. Using vaccination with attenuated strains of HSV-2 as a paradigm for an effective herpes virus vaccine, he is investigating the activation and expression of B and T cell effector function in the genital tract and peripheral nervous system against HSV-2 infection. Additionally, he is examining the differentiation and maintenance of antigen-specific memory CD4+ and CD8+ T cells within the genital mucosa and sensory ganglia. Dr. Milligan is also interested in interactions between viral pathogens and the innate immune system and how these interactions shape the adaptive immune responses to West Nile Virus. Dr. Milligan is active in the education of graduate and medical students.

Dr. Reece serves as Assistant Director for the World Health Organization Collaborating Center (WHO CC) for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases. She is responsible for helping to manage and organize the WHO CC Internship Program. To that end, she helps recruit graduate/medical students for the internships and generates and maintains protocols for the student interns to follow that will help them navigate the intern process. She organizes and maintains communication between the WHO CC and collaborators and helps manage the associated projects. In addition, Dr. Reece manages WHO CC annual reports, maintains the intern database and the SIVS website.

Dr. Shi has pioneered flavivirus drug discovery in leading pharmaceutical companies and academia. He is also an internationally recognized leader in the field of flavivirus biology and vaccine development. He has published over 210 peer-reviewed articles and served as Editor (ACS Infectious Diseases, Journal of General Virology, and npj Vaccines) and Editorial Board member (Journal of Virology, Virology, and Antiviral Research). Dr. Shi’s lab integrates both academic and industrial expertise for basic and translational research.